IBD
Myths and Misconceptions in the Management of Elderly Patients With Inflammatory Bowel Disease
Feature
Recent Developments and Novel Therapeutics in Alcohol-Associated Liver Disease
Abstract: The landscape of alcohol-associated liver disease (ALD) has changed dramatically in the past two decades. Gut dysbiosis has emerged as a critical driver of ALD […]
From Recent Issues
Feature
Recent Developments and Novel Therapeutics in Alcohol-Associated Liver Disease
Abstract: The landscape of alcohol-associated liver disease (ALD) has changed dramatically in the past two decades. Gut dysbiosis has emerged as a critical driver of ALD […]
Feature
How to Choose Among Interleukin-23 Inhibitors for Inflammatory Bowel Disease
Abstract: Interleukin (IL)-23 plays a central role in the immunopathogenesis of Crohn’s disease (CD) and ulcerative colitis (UC). Recent evidence has shown that intestinal inflammation may […]
Feature
Therapeutic Drug Monitoring in Adolescents and Children With Inflammatory Bowel Disease
Abstract: Proactive longitudinal therapeutic drug monitoring (TDM) is the standard of care for pediatric patients with inflammatory bowel disease (IBD). This is important because children and […]
Supplements
Highlights in MASH From the American College of Gastroenterology 2026 Annual Scientific Meeting
A Review of Selected Presentations From the ACG 2026 Annual Scientific Meeting October 9-14, 2026 • Nashville, Tennessee Machine Learning Models of Noninvasive Tests to Predict […]
Highlights in Crohn’s Disease From DDW 2026
A Review of Selected Presentations From Digestive Disease Week 2026 May 2-5, 2026 • Chicago, Illinois Risankizumab Reduces Symptoms and Concomitant Therapy Use and Improves Health-Related […]
Highlights in Ulcerative Colitis From DDW 2026
A Review of Selected Presentations From Digestive Disease Week 2026 May 2-5, 2026 • Chicago, Illinois Efficacy and Safety of Guselkumab for Ulcerative Colitis Through Week […]